India New Zealand trade deal boosts Supriya Lifescience prospects
after close1 source ↓written by the desknot a recommendation
A new India–New Zealand free trade deal is set to enhance trade opportunities for export-oriented pharma and chemicals stocks. Tariff cuts and clearer regulations may lead to increased growth for companies like Supriya Lifescience, which specializes in active pharmaceutical ingredients. Traders should monitor this sector for potential gains. 📈
Not investment advice. For informational purposes only.